Growing momentum for V-BID in Medicare Advantage plans
Responding to growing momentum for clinical nuance in Medicare Advantage, the V-BID Center has provided substantial comments on the recent CMS RFI regarding a V-BID demonstration project in Medicare Advantage (MA) and Medicare Advantage prescription drug plans (MA-PD). These comments contain explicit, evidence-based recommendations to address some of Medicare’s most complex challenges regarding effective benefit design features, cost-sharing parameters, consumer/provider engagement methods, quality measures, actuarial value considerations, among other topics, while also exploring potential barriers to implementation. This RFI capitalizes on ongoing interest in V-BID at the federal/legislative level. Earlier this September, US Senators John Thune (R-SD) and Debbie Stabenow (D-MI) introduced legislation S.2783: The V-BID for Better Care Act of 2014. The bipartisan, bicameral bill directs the Secretary of Health and Human Services to establish a three-year demonstration program allowing participating MA plans to test V-BID principles of reduced copayments and coinsurance for high-performing providers, evidence-based [...]